The strongest reported subjective methamphetamine effect need not occur at the time of the highest measured plasma concentration. Logan’s 2002 review describes a smoking study in which the subjective peak preceded the plasma peak by roughly two to three hours. A concentration curve and a person’s experience therefore cannot be treated as the same clock.
What does “peak” mean?
A pharmacokinetic peak concerns a measured concentration in a named specimen. A subjective peak concerns a rating or reported experience. A performance peak or deficit concerns an objective task. Each requires its own endpoint, measurement schedule and comparison condition.
These distinctions are especially important when someone uses the phrase “peak intoxication.” Without identifying which outcome was measured, the phrase may silently combine exposure, feeling and functional ability into one conclusion.
What the supplied historical source reports
In its discussion of acute dosing, Logan’s narrative review summarizes smoking and intravenous methamphetamine research. It reports peak subjective effects approximately 18 minutes after smoking began and 17 minutes after intravenous injection. For smoking, it states that the subjective peak preceded peak plasma concentration by approximately two to three hours, which the review treats as evidence of acute tolerance.
In the pharmacokinetic discussion, the review describes smoking experiments with a nominal 30-mg methamphetamine hydrochloride dose, an average estimated intake of 22 mg, and a mean peak plasma concentration of 0.047 mg/L at around 2.5 hours, followed by a plateau lasting about another two hours. The nominal material available and the estimated amount taken in were different quantities. Those values should not be collapsed into an exact administered systemic dose.
These findings are reported through the supplied 2002 review. The underlying experiments were not independently reanalyzed for this article. The numbers describe historical controlled conditions; they do not provide a reconstruction rule for an unknown exposure.
Acute tolerance is not the same as clearance
A reported effect can decline while drug remains measurable or while the measured concentration is still rising. That observation concerns the relationship between concentration and effect over time. It should not be described as proof that the body has already eliminated most of the drug.
Nor does reduced subjective intensity establish recovery of every function. Someone’s reported high is an outcome worth measuring, but it is not a substitute for attention, judgment, coordination or driving performance. The cited timing comparison did not validate a universal point at which people become fit to drive.
Why a single specimen cannot locate a person on every curve
A later plasma result supplies one observation at collection. To place it on a concentration–time trajectory requires assumptions about route, dose, repeated administration, absorption and elimination. To use it to locate a subjective or functional trajectory requires additional evidence linking those endpoints.
The review notes variable elimination half-lives and the importance of urinary pH. Its smoking discussion also considers possible contributions from swallowed material and delayed absorption. An investigator cannot select one historical average and assume that an unknown individual followed exactly the same path.
Plasma must also remain plasma. These reported values are not whole-blood measurements, and they should not be assigned directly to a whole-blood result without an adequately supported matrix comparison.
Questions that make a timing opinion clearer
Ask when administration reportedly began and ended; when each specimen and observation was obtained; whether more than one dose was possible; and whether “peak” means concentration, self-report or a measured task. Record the uncertainty instead of filling gaps with an average curve.
The defensible lesson is a temporal distinction: a subjective high can peak earlier than plasma concentration under the conditions summarized in this historical review. That finding challenges a one-clock interpretation while leaving individual impairment and event causation to a separate assessment.
Scientific source
Logan BK. Methamphetamine—Effects on Human Performance and Behavior. Forensic Science Review. 2002;14(1–2):133–151, sections IV.B and V.A. PubMed record, PMID 26256490. Historical review; study-level findings above are attributed to this secondary source.
Leave a Reply